Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Week In Review: BeiGene Signs $2.2 Billion Deal With Novartis For PD-1

Beijing's BeiGene out-licensed ex-China rights for tislelizumab, its anti-PD-1 antibody, to Novartis​​​ in a $2.2 billion agreement. The deal includes a $650 million upfront payment to BeiGene, plus up to $1.3 billion in regulatory milestones.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.